BioOutsource Opens New Facility in Glasgow

Author(s)Pharmaceutical Technology Editors

The investment doubles the company’s capacity to meet increasing demand for its biologics contract testing and biosimilar characterization services.

BioOutsource, part of Sartorius Stedim Biotech Group, has opened a new facility in Glasgow. The investment follows the increasing demand for the company’s biologics contract testing and biosimilar characterization services. The new facility doubles BioOutsource’s capacity for future growth and will create approximately 50 new jobs for scientific and technical professionals in the next six months, according to the company.

Source: BioOutsource

Articles in this issue

over 10 years ago

Article

CDMOs Move Slowly with Expansion Plans

over 10 years ago

Article

Accelerating Continuous API Synthesis

over 10 years ago

Article

Needle in the Haystack, or Rembrandt in the Attic? Drug Repurposing's New Strategy

over 10 years ago

Article

Silicone Rubber Pieces Spur Recall of Teva Product

over 10 years ago

Article

Baxter Recalls IV Solution for Container and Particulate Issues

over 10 years ago

Article

Indian API Manufacturer Cited for Recordkeeping Failures

over 10 years ago

Article

Xcelience Makes Investment in Powdersize

over 10 years ago

Article

FDA Issues Quality Metrics Draft Guidance Document for Comment

over 10 years ago

Article

EMA Issues Guideline on Fast Tracking Drugs for Unmet Needs

over 10 years ago

Article

SafeBridge Updates Potent API and Drug Manufacturer Status

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!